These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23155221)

  • 1. Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist.
    Solomon DH; Rassen JA; Kuriya B; Chen L; Harrold LR; Graham DJ; Lewis JD; Lii J; Liu L; Griffin MR; Curtis JR
    Ann Rheum Dis; 2013 Nov; 72(11):1813-8. PubMed ID: 23155221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs.
    Solomon DH; Curtis JR; Saag KG; Lii J; Chen L; Harrold LR; Herrinton LJ; Graham DJ; Kowal MK; Kuriya B; Liu L; Griffin MR; Lewis JD; Rassen JA
    Am J Med; 2013 Aug; 126(8):730.e9-730.e17. PubMed ID: 23885678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
    Listing J; Strangfeld A; Kekow J; Schneider M; Kapelle A; Wassenberg S; Zink A
    Arthritis Rheum; 2008 Mar; 58(3):667-77. PubMed ID: 18311816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis.
    Setoguchi S; Schneeweiss S; Avorn J; Katz JN; Weinblatt ME; Levin R; Solomon DH
    Am Heart J; 2008 Aug; 156(2):336-41. PubMed ID: 18657665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF-alpha antagonists.
    Curtis JR; Kramer JM; Martin C; Saag KG; Patkar N; Shatin D; Burgess M; Xie A; Braun MM
    Rheumatology (Oxford); 2007 Nov; 46(11):1688-93. PubMed ID: 17938138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Heart Failure in Rheumatoid Arthritis Patients Treated with Tumor Necrosis Factor-α Inhibitors.
    Chen HK; Shao SC; Weng MY; Lin SJ; Hung MJ; Chan YY; Lai EC
    Clin Pharmacol Ther; 2021 Dec; 110(6):1595-1603. PubMed ID: 34496051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.
    Winthrop KL; Baddley JW; Chen L; Liu L; Grijalva CG; Delzell E; Beukelman T; Patkar NM; Xie F; Saag KG; Herrinton LJ; Solomon DH; Lewis JD; Curtis JR
    JAMA; 2013 Mar; 309(9):887-95. PubMed ID: 23462785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA.
    Závada J; Lunt M; Davies R; Low AS; Mercer LK; Galloway JB; Watson KD; Symmons DP; Hyrich KL;
    Ann Rheum Dis; 2014 Jan; 73(1):252-5. PubMed ID: 23644671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Necrosis Factor Inhibition and Head and Neck Cancer Recurrence and Death in Rheumatoid Arthritis.
    Phillips C; Zeringue AL; McDonald JR; Eisen SA; Ranganathan P
    PLoS One; 2015; 10(11):e0143286. PubMed ID: 26599370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors.
    Segan J; Staples MP; March L; Lassere M; Chakravarty EF; Buchbinder R
    Intern Med J; 2015 Mar; 45(3):310-8. PubMed ID: 25565419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-α antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis.
    Lane MA; McDonald JR; Zeringue AL; Caplan L; Curtis JR; Ranganathan P; Eisen SA
    Medicine (Baltimore); 2011 Mar; 90(2):139-145. PubMed ID: 21358439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.
    Mercer LK; Green AC; Galloway JB; Davies R; Lunt M; Dixon WG; Watson KD; ; Symmons DP; Hyrich KL;
    Ann Rheum Dis; 2012 Jun; 71(6):869-74. PubMed ID: 22241900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of tuberculosis comparison in new users of antitumour necrosis factor-α and with existing disease-modifying antirheumatic drug therapy.
    Chan MJ; Wen YH; Huang YB; Chuang HY; Tain YL; Lily Wang YC; Hsu CN
    J Clin Pharm Ther; 2018 Apr; 43(2):256-264. PubMed ID: 29119581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.
    Davies R; Galloway JB; Watson KD; Lunt M; Symmons DP; Hyrich KL;
    Ann Rheum Dis; 2011 Oct; 70(10):1831-4. PubMed ID: 21784722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.
    Lee JL; Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
    Arthritis Res Ther; 2018 Aug; 20(1):171. PubMed ID: 30086795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalization for musculoskeletal disorders in rheumatoid arthritis patients: a population-based study.
    Machado MA; Bernatsky S; Bessette L; Nedjar H; Rahme E
    BMC Musculoskelet Disord; 2016 Jul; 17():298. PubMed ID: 27431503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of rheumatoid arthritis disease characteristics on heart failure.
    Myasoedova E; Crowson CS; Nicola PJ; Maradit-Kremers H; Davis JM; Roger VL; Therneau TM; Gabriel SE
    J Rheumatol; 2011 Aug; 38(8):1601-6. PubMed ID: 21572155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis.
    Bernatsky S; Hudson M; Suissa S
    Rheumatology (Oxford); 2005 May; 44(5):677-80. PubMed ID: 15784627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases.
    Silvagni E; Bortoluzzi A; Carrara G; Zanetti A; Govoni M; Scirè CA
    BMJ Open; 2018 Sep; 8(9):e021447. PubMed ID: 30206082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.